Lack of association in Japanese patients between neuroleptic malignant syndrome and the TaqI A polymorphism of the dopamine D2 receptor gene

Psychiatric Genetics

Volumn 13, Issue 1, 2003, Pages 55-57

  Kishida, Ikuko ^a,d   Kawanishi, Chiaki ^a   Furuno, Taku ^a   Matsumura, Takehiko ^a,b   Hasegawa, Hana ^a,b   Sugiyama, Naoya ^c   Suzuki, Kyoko ^a   Yamada, Yoshiteru ^a   Kosaka, Kenji ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b Fujisawa City Hospital   (Japan)

^c Numazu City Hospital   (Japan)

^d NONE   (Japan)

Author keywords

Adverse effect; Dopamine D2 receptor (DRD2); Genetic polymorphism; Neuroleptic malignant syndrome; TaqI A

Indexed keywords

DOPAMINE 2 RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENOTYPE; HUMAN; MALE; NEUROLEPTIC MALIGNANT SYNDROME; PRIORITY JOURNAL;

ANTIPSYCHOTIC AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENOTYPE; HUMANS; JAPAN; NEUROLEPTIC MALIGNANT SYNDROME; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, DOPAMINE D2; SCHIZOPHRENIA; TAQ POLYMERASE;

EID: 0037337561     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041444-200303000-00010     Document Type: Article

References (17)

1. 2 receptor locus. Biol Psychiatry 34:204-209.
2. Cohen J (1988). Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Edbaum Associates; pp. 179-213.
3. Deuschl G, Oepen G, Hermle L (1987). Neuroleptic malignant syndrome: observations on altered consciousness. Pharmacopsychiatry 20:168-170.
4. 2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am J Hum Genet 45:778-785.
5. 2 locus. Hum Mol Genet 2:2197.
6. 2A receptor genes. Am J Psychiatry 155:1275-1277.
7. Kawanishi C, Furuno T, Onishi H, Sugiyama N, Suzuki K, Matsumura T, et al. (2000). Lack of association in Japanese patients between neuroleptic malignant syndrome and debrisoquine 4-hydroxylase genotype with low enzyme activity. Psychiatric Genet 10:145-147.
8. 2 gene. Psychopharmacology 149:246-250.
9. 2) polymorphism and prolactin response to bromperidol. Am J Med Genet 105:271-274.
10. 2 dopamine receptor gene: a review of association studies in alcoholism and phenotypes. Alcohol 16:33-45.
11. Otani K, Hcriuchi M, Kondo T, Kanekc S, Fukushima Y (1991). Is the predisposition to neuroleptic malignant syndrome genetically transmitted? Br J Psychiatry 158:850-853.
12. Pope GH, Keck PE, McElroy SL (1986). Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. Am J Psychiatry 143:1227-1233.
13. 2 receptor gene in a patient with neuroleptic malignant syndrome. Am J Med Genet 60:228-230.
14. 2 receptor gene. Am J Psychiatry 158:802-804.
15. 2 receptor polymorphism at the TaqI A locus and therapeutic response to nemonapride, a selective dopamine antagonist, in schizophrenic patients. Pharmacogenetics 10:335-341.
16. 2 receptor gene with predisposition to neuroleptic malignant syndrome. Am J Psychiatry 158:1714-1716.
17. 2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 7:479-484.